<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16587">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01848509</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00713-40</org_study_id>
    <secondary_id>K120501</secondary_id>
    <nct_id>NCT01848509</nct_id>
  </id_info>
  <brief_title>Telemedicine for Sleep Apnea Patients</brief_title>
  <acronym>Respir@dom</acronym>
  <official_title>A Telemedicine System for the Follow-up of Patients With SAS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: Set up an interoperable telemedicine system for the follow-up of patients with
      sleep apnea syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The medico-economics protocol will use the MAST (Methodology for Assessment of Telemedicine)
      criteria.  200 patients will be randomized into 2 arms (telemedicine with GPRS transmission
      of CPAP data from patients' home and classical follow-up) during the 3 first months of the
      follow-up. The main end-point is CPAP compliance with the aim of detecting a mean  increase
      of at least 1hr in the use of CPAP.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>CPAP adherence measured by the number of hours of nightly use</measure>
    <time_frame>3 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>economics: cost estimation: investment and running costs</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>SF36 (french version) and FOSQ (Functional Outcomes of Sleep Questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Organizational changes of home care providers and medical structures</measure>
    <time_frame>9 months after the first patient inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of healthcare professionals (autoquestionnaire RENEWING HEALTH)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients satisfaction</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Without telemonitoring</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Without teletransmission of alerts</description>
  </arm_group>
  <arm_group>
    <arm_group_label>With telemonitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>With teletransmission of alerts</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>With teletransmission</intervention_name>
    <description>Teletransmission of alerts</description>
    <arm_group_label>With telemonitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AHI &gt; 30/hr

          -  hypersomnolence

          -  agreement for the use of CPAP

          -  internet and GSM connection

        Exclusion Criteria:

          -  central apnea &gt;20%,

          -  pneumothorax,

          -  severe nasal obstruction,

          -  previous pharyngeal surgery,

          -  severe COPD,

          -  heart failure,

          -  previous use of CPAP,

          -  no social security coverage,

          -  unavailability,

          -  no GSM and internet network
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre ESCOURROU, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP-HP - Antoine Béclère Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre ESCOURROU, MD, PhD</last_name>
    <phone>33(0)1-45374810</phone>
    <email>pierre.escourrou@abc.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique - Hôpitaux de Paris, Béclère Hospital</name>
      <address>
        <city>Clamart</city>
        <zip>92141</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie PUISAIS, CRA</last_name>
      <phone>+33(0)-145374810</phone>
      <email>nathalie.puisais@abc.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre ESCOURROU, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 28, 2014</lastchanged_date>
  <firstreceived_date>April 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CPAP</keyword>
  <keyword>adherence</keyword>
  <keyword>SAOS</keyword>
  <keyword>telemedicine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
